Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Cytotechnology
2000 Nov 01;343:225-35. doi: 10.1023/A:1008152205697.
Show Gene links
Show Anatomy links
Basolateral and canalicular transport of xenobiotics in the hepatocyte: A review.
Diaz GJ
.
???displayArticle.abstract???
The molecular and functional characterization of severalproteins involved in the uptake and excretion of xenobioticsand endogenous compounds in the hepatocyte has been achievedthrough intensive research conducted in the past few years.These studies have lead to the identification of specificmembrane transporters located in the basolateral andcanalicular membrane domains of the hepatocyte. The organicanion-transporting polypeptide (OATP), present in thebasolateral membrane of the hepatocyte, is responsible for thetranslocation of xenobiotics from the sinusoidal space into thehepatocyte. Once inside the cell, unconjugated neutral, anionicand cationic xenobiotics can be secreted into bile by themultidrug-resistance P-glycoprotein 1 (MDR1). Conjugatedxenobiotics (e.g. glucuronides and glutathione conjugates) aresecreted into bile by the canalicular multispecific organicanion transporter (cMOAT). Other transporters play keyphysiological roles, including the basolateral uptake of bilesalts (sodium-taurocholate cotransporter, NTCP) and thesecretion into bile of conjugated and unconjugated bile salts(bile salt export pump, BSEP) and phospholipids (MDR2).Experimental approaches used to investigate the role of thebasolateral and canalicular transporters in the hepatocyte haveincluded both in vivo and in vitro models. Animalmodels lacking canalicular transporters include the;hyperbilirubinemic' rats (Groningen-Yellow (GY), Eisaihyperbilirubinemic (EHB) and TR(-) rats), which aredeficient in the cMOAT protein, and ;knock-out' mice, lackingeither the MDR1 or MDR2 transporter. Although no animal modelsare currently available for the study of basolateraltransporters, their function has been conveniently investigatedthrough heterologous expression in Xenopus laevis oocytesand also with basolateral membrane vesicles isolated fromhepatocytes. The total number of basolateral and canaliculartransport proteins present in the hepatocyte is still unknown,but current knowledge indicates that there are at least fourpresent in the basolateral membrane and five in the canaliculardomain. The present review focuses on the current knowledgeabout the most relevant hepatocyte transporters involved in theuptake of foreign and endogenous compounds from the sinusoidalspace and in their active secretion into bile. The first partof the review deals with the basolateral (sinusoidal) transportof organic anions, and the major basolateral transporters (e.g.NTCP, OATP) are described here, both in terms of their knownbiochemistry and physiology. In the second part of the review,the canalicular (apical) transport of organic anions isdiscussed and the biochemistry and physiological role of MDR1,MDR2, cMOAT and BSEP is described in detail. The concludingremarks point out areas of research that need to be addressedin order to answer important questions that still remainunanswered in this important field of study.
Abe,
Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2.
1998, Pubmed
Abe,
Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2.
1998,
Pubmed
Benet,
Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery.
1999,
Pubmed
Bossuyt,
Multispecific amphipathic substrate transport by an organic anion transporter of human liver.
1996,
Pubmed
,
Xenbase
Bossuyt,
Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver.
1996,
Pubmed
,
Xenbase
Büchler,
cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats.
1996,
Pubmed
Childs,
Identification of a sister gene to P-glycoprotein.
1995,
Pubmed
Cole,
Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.
1992,
Pubmed
de Vree,
Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis.
1998,
Pubmed
Elferink,
Hepatic canalicular membrane 1: The role of mdr2 P-glycoprotein in hepatobiliary lipid transport.
1997,
Pubmed
Evans,
A biochemical dissection of the functional polarity of the plasma membrane of the hepatocyte.
1980,
Pubmed
Fardel,
The P-glycoprotein multidrug transporter.
1996,
Pubmed
Garrigos,
Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model.
1997,
Pubmed
Gerloff,
The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver.
1998,
Pubmed
,
Xenbase
Hagenbuch,
Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter.
1994,
Pubmed
,
Xenbase
Hagenbuch,
Functional expression cloning and characterization of the hepatocyte Na+/bile acid cotransport system.
1991,
Pubmed
,
Xenbase
Hall,
Molecular and physical mechanisms of first-pass extraction.
1999,
Pubmed
Hirohashi,
Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats.
1998,
Pubmed
Horz,
Bumetanide is not transported by the Ntcp or by the oatp: evidence for a third organic anion transporter in rat liver cells.
1996,
Pubmed
,
Xenbase
Ito,
Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR.
1997,
Pubmed
Ito,
Functional analysis of a canalicular multispecific organic anion transporter cloned from rat liver.
1998,
Pubmed
Jacquemin,
Expression cloning of a rat liver Na(+)-independent organic anion transporter.
1994,
Pubmed
,
Xenbase
Juliano,
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.
1976,
Pubmed
Kajihara,
A splice mutation in the human canalicular multispecific organic anion transporter gene causes Dubin-Johnson syndrome.
1998,
Pubmed
Kauffmann,
Induction of hepatic mrp2 (cmrp/cmoat) gene expression in nonhuman primates treated with rifampicin or tamoxifen.
1998,
Pubmed
Keppler,
Hepatic canalicular membrane. Introduction: transport across the hepatocyte canalicular membrane.
1997,
Pubmed
Kim,
Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein.
1999,
Pubmed
Kiuchi,
cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3).
1998,
Pubmed
Kullak-Ublick,
Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver.
1995,
Pubmed
,
Xenbase
Kusuhara,
The role of P-glycoprotein and canalicular multispecific organic anion transporter in the hepatobiliary excretion of drugs.
1998,
Pubmed
Lincke,
Structure of the human MDR3 gene and physical mapping of the human MDR locus.
1991,
Pubmed
Makowski,
Participation of the multispecific organic anion transporter in hepatobiliary excretion of glutathione S-conjugates, drugs and other xenobiotics.
1997,
Pubmed
Masuda,
Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats.
1997,
Pubmed
Noé,
Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain.
1997,
Pubmed
,
Xenbase
Oude Elferink,
The role of the canalicular multispecific organic anion transporter in the disposal of endo- and xenobiotics.
1994,
Pubmed
Paulusma,
Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione.
1999,
Pubmed
Paulusma,
Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene.
1996,
Pubmed
Paulusma,
The canalicular multispecific organic anion transporter and conjugated hyperbilirubinemia in rat and man.
1997,
Pubmed
Paulusma,
A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome.
1997,
Pubmed
Perkins,
Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2, or Bcl-x(L).
2000,
Pubmed
Schinkel,
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins.
1997,
Pubmed
Schinkel,
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs.
1994,
Pubmed
Sekine,
Identification of multispecific organic anion transporter 2 expressed predominantly in the liver.
1998,
Pubmed
,
Xenbase
Simonson,
Molecular cloning and characterization of a novel liver-specific transport protein.
1994,
Pubmed
Smit,
Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease.
1993,
Pubmed
Strautnieks,
A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis.
1998,
Pubmed
Taniguchi,
A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation.
1996,
Pubmed
Thiebaut,
Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.
1987,
Pubmed
Trauner,
Molecular pathogenesis of cholestasis.
1998,
Pubmed
Uchiumi,
Isolation of a novel human canalicular multispecific organic anion transporter, cMOAT2/MRP3, and its expression in cisplatin-resistant cancer cells with decreased ATP-dependent drug transport.
1998,
Pubmed
Váradi,
Membrane topology of the human multidrug resistance-associated protein (MRP) and its homologs.
1998,
Pubmed
Wada,
Mutations in the canilicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome.
1998,
Pubmed
